Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Trial of the Arctx Cool Catheter in Acute Pancreatitis

NCT: NCT07698119 · NOT_YET_RECRUITING

NCT IDNCT07698119
StatusNOT_YET_RECRUITING
Start Date2026-08-01
Completion2028-03-31
SponsorArctx Medical, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

Researchers will compare people who get the ACC Set plus standard of care to people who get standard of care alone. This will show whether adding the ACC Set helps. Participants will: Join one of two groups, chosen by chance: the ACC Set plus standard of care, or standard of care alone. Have the cooling tube in place for up to 3 days, if they are in the ACC Set group. Have blood tests and pain checks every few hours during their hospital stay. Return for follow-up visits about 7, 14, and 30 days later.

Frequently Asked Questions

What is A Trial of the Arctx Cool Catheter in Acute Pancreatitis?

A Trial of the Arctx Cool Catheter in Acute Pancreatitis is a clinical trial registered under NCT07698119. Current status: NOT_YET_RECRUITING.

What is the status of NCT07698119?

The current status of NCT07698119 (A Trial of the Arctx Cool Catheter in Acute Pancreatitis) is: NOT_YET_RECRUITING.

When did A Trial of the Arctx Cool Catheter in Acute Pancreatitis start?

A Trial of the Arctx Cool Catheter in Acute Pancreatitis started on 2026-08-01.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.